Product Development Partnerships Hit Their Stride: Lessons From Developing A Meningitis Vaccine For Africa
about
Meningococcal serogroup B vaccine in Italy: state-of-art, organizational aspects and perspectivesTechnical Development of a New Meningococcal Conjugate VaccineAmbiguous Capture: Collaborative Capitalism and the Meningitis Vaccine ProjectEnhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013Strengthening medical product regulation in low- and middle-income countriesHHS--supporting global immunization through policies, programs, and partnershipsDevelopment of a group A meningococcal conjugate vaccine, MenAfriVac(TM).Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa.Neurology and international organizationsGlobal epidemiology of invasive meningococcal disease.Future prospects for new vaccines against sexually transmitted infections.Meningococcal disease: changes in epidemiology and prevention.Serogroup A meningococcal conjugate vaccines in Africa.Sustainable Financing of Innovative Therapies: A Review of Approaches.Screening of the 'Stasis Box' identifies two kinase inhibitors under pharmaceutical development with activity against Haemonchus contortus.Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps.Geneva-Seattle collaboration in support of developing country vaccine manufacturing.Product Development and Commercialization of Diagnostic or Life Science Products for Scientists and Researchers.
P2860
Q26770702-C1BE3247-8C35-4FC3-B3F3-D8D7C1BA808BQ26778279-3048F8F0-FA63-416E-B4C8-D32E05D12BE2Q28598111-EE22734E-CFF5-4064-AFD9-85E0CBA1C071Q28654939-98F9D4FE-2823-4A17-A073-F434FA704C73Q31105852-058D4E23-DAC1-4AEB-9229-24C099A305C7Q34002755-C306DFAE-CC90-4968-A928-DC3F144EDEE6Q34267478-45572DED-43ED-41BE-B4F2-B4C0589BDAF0Q34785389-558FF5FB-6EC3-4181-BE78-4339B8D5F809Q37170157-4C48D88A-4B72-4BEE-B160-B470CE849E9DQ37359946-19D88022-D1C1-4CF4-AE46-73EAEBBBACE8Q37665012-DF3FE6CD-B2C5-4F86-8C2C-E66D5935CD96Q38052545-0D949A85-3955-4587-8741-C6E4F9F84F28Q38584375-23AF62E0-0DD4-4909-B2FA-FC09B7F9823CQ38850678-FFBF4D12-00E1-4D95-B953-C1A3FA3863E4Q40146751-94C3E541-03C5-48A3-AEBE-6E070AEA6E0EQ47920054-CAECF608-D5C9-4F1C-B45E-8E8BECE5EB8FQ48769122-BF708A9F-66FB-4274-86AF-2B1934123A3CQ50642969-DFFC403E-1D19-468C-B104-9FB835AE5088
P2860
Product Development Partnerships Hit Their Stride: Lessons From Developing A Meningitis Vaccine For Africa
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Product Development Partnershi ...... Meningitis Vaccine For Africa
@ast
Product Development Partnershi ...... Meningitis Vaccine For Africa
@en
Product Development Partnershi ...... Meningitis Vaccine For Africa
@en-gb
Product Development Partnershi ...... Meningitis Vaccine For Africa
@nl
type
label
Product Development Partnershi ...... Meningitis Vaccine For Africa
@ast
Product Development Partnershi ...... Meningitis Vaccine For Africa
@en
Product Development Partnershi ...... Meningitis Vaccine For Africa
@en-gb
Product Development Partnershi ...... Meningitis Vaccine For Africa
@nl
altLabel
Product development partnershi ...... meningitis vaccine for Africa
@en
prefLabel
Product Development Partnershi ...... Meningitis Vaccine For Africa
@ast
Product Development Partnershi ...... Meningitis Vaccine For Africa
@en
Product Development Partnershi ...... Meningitis Vaccine For Africa
@en-gb
Product Development Partnershi ...... Meningitis Vaccine For Africa
@nl
P2093
P3181
P1433
P1476
Product development partnershi ...... meningitis vaccine for Africa
@en
P2093
Claire Champion
Lindsay Thompson
Michael E Steele
P304
P3181
P356
10.1377/HLTHAFF.2011.0295
P407
P50
P577
2011-06-01T00:00:00Z